parkinson’s disease - global drug forecast and market analysis to 2022

9
www.MarketResearchReports.com PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022 Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.

Upload: market-research-reports-inc

Post on 20-Jun-2015

119 views

Category:

Healthcare


0 download

DESCRIPTION

Market Research Reports, Inc. has announced the addition of “PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022” research report to their offering. See more at- http://mrr.cm/ZQd

TRANSCRIPT

Page 1: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

PharmaPoint: Parkinson’s

Disease - Global Drug Forecast and Market Analysis

to 2022

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

Page 2: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Introduction to Report

Launch Date: March 31, 2014

Number of Pages: 327

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 9,995

Price For Site License: USD 1,990

Price For Global User License: USD 29,985

Delivery Time: Within 24 Hours (During Working Days)

Page 3: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

About the Report

Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly.

It is expected that the prevalence of Parkinson’s disease in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Brazil will increase from 3.2m people in 2012 to 4.3m people in 2022, driven by an aging population in all markets. Dopaminergic therapies have been fairly effective in treating bradykinesia, but several unmet needs remain.

Page 4: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Research Findings

Global Parkinson’s Disease Therapeutics Market Value to Reach $5.3 Billion by 2022, as Current Pipeline Addresses Advanced Patients’ Needs, says Publisher

As the prevalence of Parkinson’s Disease (PD) continues to grow thanks to an ageing population, its treatment market value is expected to increase from $3.6 billion in 2012 to $5.3 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 4%, says research and consulting firm by Publisher.

According to the company’s latest report the US will have the largest PD therapeutics market share of 44% by 2022, expanding from 32% in 2012. This will be followed by Japan, Brazil and Germany, with respective shares of 13%, 11% and 10%.

Page 5: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Research Findings Continues..

Population increases, especially in the elderly, will be a key driving force in the global PD market.

With several small biotech and pharmaceutical companies involved in mid-stage development of PD products, there will be ample opportunity for partnerships with Big Pharma.

Levodopa based therapy will remain the gold standard of care with advancements in administration, including the introduction of slow-release formulations and an emergency use inhaler.

Several unmet needs are expected to remain after the forecast period, as advancements in the control of non-motor symptoms and in the development of disease-modifying therapies are lagging.

Page 6: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Report Coverage

1. Introduction2. Disease Overview3. Epidemiology4. Disease Management5. Competitive Assessment6. Opportunity and Unmet Need7. Pipeline Assessment8. Current and Future Players9. Market Outlook10.Appendix

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 7: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Company Coverage

1. Merck2. Roche3. AbbVie4. UCB5. GlaxoSmithKline6. Novartis7. Orion8. Newron9. Civitas10.Impax11.Lundbeck

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 8: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

Page 9: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/ZQd

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)